Lucid Diagnostics Inc (LUCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,078 | -16,772 | -9,816 | -3,653 | -8,280 |
| Depreciation Amortization | 4 | 3 | 3 | 3 | 0 |
| Accounts receivable | -200 | -200 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -665 | 781 | -517 | -1,269 | N/A |
| Other Working Capital | -2,250 | -460 | -1,058 | -1,273 | 223 |
| Other Operating Activity | 13,521 | 8,857 | 5,779 | 2,877 | 2,428 |
| Operating Cash Flow | $-17,668 | $-7,791 | $-5,609 | $-3,315 | $-5,629 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -862 | -38 | -10 | -9 | 0 |
| Investing Cash Flow | $-862 | $-38 | $-10 | $-9 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 70,000 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 2,075 | 7,739 | 7,739 | 3,300 | 5,584 |
| Financing Cash Flow | $72,075 | $7,739 | $7,739 | $3,300 | $5,584 |
| Beginning Cash Position | 111 | 111 | 111 | 111 | 156 |
| End Cash Position | 53,656 | 21 | 2,231 | 87 | 111 |
| Net Cash Flow | $53,545 | $-90 | $2,120 | $-24 | $-45 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,668 | -7,791 | -5,609 | -3,315 | -5,629 |
| Capital Expenditure | -862 | -38 | -10 | -9 | N/A |
| Free Cash Flow | -18,530 | -7,829 | -5,619 | -3,324 | -5,629 |